John
This answer briefly reviews the Q4. For Q1 2026, profit rose 8% on RTD growth. EPS was 36c vs 33 the prior year. Sales were a record $75.4M, up 16%. Growth was entirely organic and was boosted by provincial trade measures. EBITDA was also a record, at $20.3M and up 4%. The company did gain market share. There are no analysts/estimates. We like the renewed growth profile but some of it is of course because US products have been restricted. As a small cap, it is priced well, but we do not see huge growth ahead. We would consider it 80% for income, and 20% for growth. Shares could do better certainly in a risk-off market.